Strategic Initiative: Nationwide Commercialization Platform for Cubo RT-PCR System
ASMS (formerly Bartronics India Limited) and Huwel Lifesciences are strengthening their collaboration to build a nationwide commercialization platform for Cubo, Huwel's ultra-compact RT-PCR system. The initiative aims to expand access to molecular diagnostics across India's private healthcare sector, including hospitals, diagnostic centres, research institutions, and smaller healthcare facilities.
Commercial Infrastructure Development
The collaboration involves establishing a dedicated sales and distribution infrastructure including:
- Recruitment of senior sales leadership
- Formation of specialized sales teams
- Development of strategic channel partnerships
The initiative will initially focus on Cubo while creating opportunities to commercialize Huwel's broader molecular diagnostics portfolio.
Product Specifications and Market Positioning
Cubo is an ultra-compact RT-PCR system designed to enable testing beyond conventional centralized laboratory environments. Its compact design allows molecular diagnostic capabilities to be deployed in smaller, more decentralized healthcare settings, potentially reducing dependence on large centralized facilities.
Target Market and Geographic Focus
The commercialization strategy will focus on:
- Private hospitals
- Diagnostic chains
- Independent laboratories
- Medical colleges
- Research institutions
- Other healthcare establishments
This is particularly relevant to India's healthcare landscape which spans metropolitan centres as well as a large and geographically distributed network of Tier-II and Tier-III cities, hospitals, and diagnostic facilities.
Sales and Distribution Strategy
The proposed sales organization will work across:
- Direct sales
- Channel partnerships
- Product demonstrations
- Installation support
- Ongoing customer engagement
Ecosystem Development
Beyond instrument deployment, ASMS and Huwel intend to develop an ecosystem around the platform comprising:
- Compatible molecular assays
- Consumables that can support recurring testing requirements
Huwel's capabilities across molecular diagnostic applications could enable Cubo installations to serve multiple testing needs rather than being limited to a single application.
Strategic Significance
For ASMS, this initiative represents an opportunity to build its presence in healthcare and diagnostics through indigenous technologies. The company is a diversified platform company focused on building scalable businesses across Financial Inclusion & Digital Services, Agri Supply Chain & Technologies, and Diagnostics & Healthcare.
For Huwel, the collaboration provides additional commercial reach and execution capabilities to support wider adoption of its products.
Management Commentary
N Vidhya Sagar Reddy, Managing Director of ASMS, stated: "The next phase of our collaboration with Huwel is focused on building the commercial infrastructure needed to take advanced molecular diagnostic technologies to a much wider customer base. Cubo's compact format creates an opportunity to bring RT-PCR capabilities closer to hospitals, laboratories and other healthcare providers, including those outside the traditional centralized laboratory ecosystem. Our focus will be on building the sales leadership, distribution network and market coverage required to support its adoption at scale across India."